Journal of Cataract & Refractive Surgery
Volume 31, Issue 11 , Pages 2137-2141, November 2005

Effect of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions on human corneal epithelium following 2 dosing regimens

From the Cornea Research Foundation of America (M.O. Price) and Price Vision Group (F.W. Price), Indianapolis, Indiana, and Nidek Technologies America (Maclellan), Greensboro, North Carolina, USA

Accepted 27 April 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by an unrestricted educational grant from Allergan, Inc., and by the Cornea Research Foundation of America.Clorissa Quillin, Laurie Potrzebowski, and Annette Cooke provided technical and logistic assistance with this clinical study.Dr. Maclellan is employed by Nidek, which sells the Confoscan 3 confocal microscope. No other author has a financial or proprietary interest in material or method mentioned.

PII: S0886-3350(05)00680-2

doi:10.1016/j.jcrs.2005.04.032

Journal of Cataract & Refractive Surgery
Volume 31, Issue 11 , Pages 2137-2141, November 2005

Article Tools

* Image Usage & Resolution